Aclarion Completes Nociscan Exams for Initial LIFEHAB Enrolled Patients in Norway Trial
Aclarion, Inc. completes Nociscan exams for patients enrolled in the LIFEHAB Trial in Norway, marking a significant step in utilizing advanced technology to improve chronic low back pain diagnosis and treatment.
This news matters as it signifies progress in utilizing advanced technology to improve the diagnosis and treatment of chronic low back pain. The results of the LIFEHAB trial, along with other evidence, could pave the way for successful reimbursement in healthcare systems, potentially impacting future treatment options for patients with chronic low back pain.
